Completed
Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model
NCT04072302
- Conditions
- Infections, Malaria, Mosquito-Borne Diseases, +3 more
- Locations
-
- Novartis Investigative Site Seattle, Washington, United States